PP
UTHR icon

Prudential plc’s United Therapeutics UTHR Stock Holding History

Prudential plc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
2,139
+1,054
+97% +$594K 0.01% 469
2026
Q1 		$643K Sell
1,085
-387
-26% -$193K ﹤0.01% 525
2025
Q4 		$717K Sell
1,472
-4,636
-76% -$2.16M 0.01% 507
2025
Q3 		$2.56M Sell
6,108
-9,044
-60% -$3.04M 0.02% 363
2025
Q2 		$4.35M Buy
15,152
+1,324
+10% +$396K 0.03% 296
2025
Q1 		$4.26M Buy
13,828
+4,094
+42% +$1.4M 0.02% 295
2024
Q4 		$3.43M Sell
9,734
-249
-2% -$91.5K 0.02% 304
2024
Q3 		$3.58M Buy
9,983
+669
+7% +$226K 0.02% 308
2024
Q2 		$2.97M Buy
9,314
+847
+10% +$224K 0.02% 335
2024
Q1 		$1.95M Buy
8,467
+7,422
+710% +$1.67M 0.01% 405
2023
Q4 		$230K Sell
1,045
-4,879
-82% -$1.12M ﹤0.01% 844
2023
Q3 		$1.34M Sell
5,924
-1,537
-21% -$354K 0.01% 470
2023
Q2 		$1.65M Buy
7,461
+435
+6% +$96.4K 0.02% 441
2023
Q1 		$1.57M Buy
7,026
+1,554
+28% +$383K 0.02% 441
2022
Q4 		$1.52M Sell
5,472
-1,012
-16% -$255K 0.02% 434
2022
Q3 		$1.36M Buy
6,484
+35
+0.5% +$7.83K 0.02% 353
2022
Q2 		$1.52M Sell
6,449
-18
-0.3% -$3.66K 0.03% 337
2022
Q1 		$1.16M Buy
+6,467
New +$1.23M 0.02% 400
2015
Q2 		– Sell
-127,398
Closed -$22M – 569
2015
Q1 		$22M Sell
127,398
-33,029
-21% -$5.04M 0.1% 191
2014
Q4 		$20.8M Sell
160,427
-6,178
-4% -$796K 0.09% 192
2014
Q3 		$21.4M Hold
166,605
– – 0.09% 194
2014
Q2 		$14.7M Buy
166,605
+59,827
+56% +$5.75M 0.06% 210
2014
Q1 		$10M Buy
+106,778
New +$10.9M 0.04% 232

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Prudential plc's UTHR Position: Q2 2026 in Review

Prudential plc increased its United Therapeutics (UTHR) stake by 97% in Q2 2026, buying an estimated $594K and bringing the position to 2,139 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #469.

Prudential plc first reported a position in UTHR in Q1 2014 and has held it in 23 quarters since. The position peaked at $22M in Q1 2015. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Prudential plc held 2,139 shares of United Therapeutics worth $1.16M as of Q2 2026.
  • Prudential plc bought 1,054 United Therapeutics shares in Q2 2026, an estimated $594K.
  • United Therapeutics made up 0.01% of Prudential plc's portfolio in Q2 2026, its #469 holding.
  • Prudential plc first reported a position in United Therapeutics in Q1 2014 and has held it in 23 quarters since.
  • Prudential plc's United Therapeutics position peaked at $22M in Q1 2015.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.